CHO Plus is creating regulatory compliant genetically engineered mammalian cells to be used by biopharmaceutical companies for therapeutic protein manufacturing. Early proof of concept experiments demonstrate CHO Plus cells to be 4.5-fold more productive than parent cells in model system. The CHO Plus approach includes patented methods for genetically engineering mammalian cells; proprietary and patented targeted transfection technology; and efficient clone screening technology.
Looking for a particular CHO Plus, Inc. employee's phone or email?
The CHO Plus, Inc. annual revenue was $3 million in 2026.
Larry Forman is the Founder, CEO of CHO Plus, Inc..
9 people are employed at CHO Plus, Inc..
CHO Plus, Inc. is based in South San Francisco, California.
The NAICS codes for CHO Plus, Inc. are [54, 5417, 54171, 541713, 541].
The SIC codes for CHO Plus, Inc. are [873, 87].